Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Caffeine Adrenergic A1 vasoconstriction Action Pathway
Homo sapiens
Drug Action Pathway
Caffeine is a stimulant present in tea, coffee, cola beverages, analgesic drugs, and agents used to increase alertness. The cardiovascular effects are extensive and can help with headaches, migraines, or other types of pain in certain circumstances. Caffeine is mainly studied using coffee which has other chemicals present in it. This means that much of the research is not well understood, and there is much conflicting data on caffeine.
Caffeine antagonizes the adenosine A2A receptor in blood vessels in the neck and head. The adenosine A2A receptors likely have a higher affinity for caffeine in the head and neck. The adenosine A2A receptor activates adenylate cyclase which catalyzes ATP into cAMP. cAMP inhibits myosin light chain kinase (MLCK), therefore the low concentration of cAMP allows MLCK to be activated by calcium activated calmodulin so it can phosphorylate myosin light chain and cause muscle contraction. The contraction of the muscle in the blood vessel causes vasoconstriction. Adenosine A2a receptors in the head and neck also stimulate the production of nitric oxide which causes vasodilation as seen in another part of this pathway, therefore, the antagonism of these receptors further leads to vasoconstriction in the head and neck. The vasoconstriction in the head and neck helps with migraines and headaches which are causes by vasodilation, but the understanding of this isn't well studied, and caffeine has also been found to cause headaches as well. Chronic caffeine intake leads to an adaptation to the vasoconstritive effects.
The opposite effects of caffeine is called the coffee-effect and based on the population of receptors in that area of the body, as well as their affinity for caffeine. This causes vasodilation in the majority of the human body, but vasoconstriction in the head and neck.
References
Caffeine Adrenergic A1 vasoconstriction Pathway References
Nowaczewska M, Wicinski M, Kazmierczak W: The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment. Nutrients. 2020 Jul 28;12(8):2259. doi: 10.3390/nu12082259.
Pubmed: 32731623
Addicott MA, Yang LL, Peiffer AM, Burnett LR, Burdette JH, Chen MY, Hayasaka S, Kraft RA, Maldjian JA, Laurienti PJ: The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate? Hum Brain Mapp. 2009 Oct;30(10):3102-14. doi: 10.1002/hbm.20732.
Pubmed: 19219847
Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V: Adenosine receptors: expression, function and regulation. Int J Mol Sci. 2014 Jan 28;15(2):2024-52. doi: 10.3390/ijms15022024.
Pubmed: 24477263
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings